Completed OBSERVATIONAL NCT00533884

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

Neurocognitive Functioning in Adults With Upper Aerodigestive System Cancers

Sponsor: National Cancer Institute (NCI)

Conditions Delirium Esophageal Cancer Head and Neck Cancer Lung Cancer Neurocognitive Impairment

Interventions Assessment of therapy complications Neurocognitive assessment Quality-of-life assessment

Updated 7 times since 2017 Last updated: Apr 5, 2017 Started: Oct 31, 2007 Primary completion: May 31, 2010 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Delirium and Esophageal Cancer, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 7 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

May 2017 — Apr 2018 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2017 — May 2017 [monthly]

Unknown Status NA

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
Vanderbilt University Medical Center

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States